Cointime

Longevity Biotech

company

About

Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.

  • 1 - 10

Highlights

Total Funding Amount
$1.04M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$155K
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Founded in 2010 by President Mr. Scott Shandler, Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.04M
Longevity Biotech has raised a total of $1.04M in funding over 2 rounds. Their latest funding was raised on Apr 2, 2015 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 2, 2015 Grant $885.50K 1 National Science Foundation — Detail
Dec 11, 2013 Grant $155K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Longevity Biotech is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Cointime
Содержание
компания